| MFS MERIDIAN JAPAN EQUITY FUND I1-USD | RVI JAPÓN | 20,49% | 68,98% | 41,77% | 102,85% |
| UBAM - POSITIVE IMPACT EMERGING EQUITY APC EUR | RVI EMERGENTES | 20,49% | 51,61% | 20,62% | · |
| UBAM - POSITIVE IMPACT EMERGING EQUITY UC USD | RVI EMERGENTES | 20,49% | 51,60% | 20,35% | · |
| BBVA BOLSA ASIA MF, FI | RVI ASIA EX-JAPÓN | 20,48% | 63,07% | 27,50% | 75,87% |
| FIDELITY FUNDS-GLOBAL TECHNOLOGY W-ACC-GBP | RVI TECNOLOGÍA | 20,48% | 96,27% | 102,58% | 562,49% |
| UBAM - POSITIVE IMPACT EMERGING EQUITY APC USD | RVI EMERGENTES | 20,48% | 51,60% | 20,87% | · |
| AMUNDI FUNDS EUROPEAN EQUITY VALUE R2 EUR (C) | RVI EUROPA VALOR | 20,47% | 63,93% | 67,93% | · |
| DWS ESG MULTI ASSET DYNAMIC LC | MIXTO FLEXIBLE | 20,47% | 56,69% | 42,21% | · |
| EDMOND DE ROTHSCHILD FUND-BIG DATA N2 EUR (HE) CAP | RVI TECNOLOGÍA | 20,47% | 74,43% | 58,32% | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 20,47% | 36,99% | -17,54% | · |
